IBDEI33C ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,49354,0)
 ;;=F03.91^^187^2447^13
 ;;^UTILITY(U,$J,358.3,49354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49354,1,3,0)
 ;;=3^Dementia w/ Bhv Dstrb,Unsp
 ;;^UTILITY(U,$J,358.3,49354,1,4,0)
 ;;=4^F03.91
 ;;^UTILITY(U,$J,358.3,49354,2)
 ;;=^5133350
 ;;^UTILITY(U,$J,358.3,49355,0)
 ;;=G31.83^^187^2447^14
 ;;^UTILITY(U,$J,358.3,49355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49355,1,3,0)
 ;;=3^Dementia w/ Lewy Bodies
 ;;^UTILITY(U,$J,358.3,49355,1,4,0)
 ;;=4^G31.83
 ;;^UTILITY(U,$J,358.3,49355,2)
 ;;=^329888
 ;;^UTILITY(U,$J,358.3,49356,0)
 ;;=F03.90^^187^2447^15
 ;;^UTILITY(U,$J,358.3,49356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49356,1,3,0)
 ;;=3^Dementia w/o Bhv Dstrb,Unsp
 ;;^UTILITY(U,$J,358.3,49356,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,49356,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,49357,0)
 ;;=F01.51^^187^2447^30
 ;;^UTILITY(U,$J,358.3,49357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49357,1,3,0)
 ;;=3^Vascular Dementia w/ Bhv Dstrb
 ;;^UTILITY(U,$J,358.3,49357,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,49357,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,49358,0)
 ;;=F01.50^^187^2447^31
 ;;^UTILITY(U,$J,358.3,49358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49358,1,3,0)
 ;;=3^Vascular Dementia w/o Bhv Dstrb
 ;;^UTILITY(U,$J,358.3,49358,1,4,0)
 ;;=4^F01.50
 ;;^UTILITY(U,$J,358.3,49358,2)
 ;;=^5003046
 ;;^UTILITY(U,$J,358.3,49359,0)
 ;;=A81.9^^187^2447^6
 ;;^UTILITY(U,$J,358.3,49359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49359,1,3,0)
 ;;=3^Atypical Virus Infection of CNS,Unspec
 ;;^UTILITY(U,$J,358.3,49359,1,4,0)
 ;;=4^A81.9
 ;;^UTILITY(U,$J,358.3,49359,2)
 ;;=^5000414
 ;;^UTILITY(U,$J,358.3,49360,0)
 ;;=A81.09^^187^2447^8
 ;;^UTILITY(U,$J,358.3,49360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49360,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease NEC
 ;;^UTILITY(U,$J,358.3,49360,1,4,0)
 ;;=4^A81.09
 ;;^UTILITY(U,$J,358.3,49360,2)
 ;;=^5000410
 ;;^UTILITY(U,$J,358.3,49361,0)
 ;;=A81.00^^187^2447^9
 ;;^UTILITY(U,$J,358.3,49361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49361,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Unspec
 ;;^UTILITY(U,$J,358.3,49361,1,4,0)
 ;;=4^A81.00
 ;;^UTILITY(U,$J,358.3,49361,2)
 ;;=^5000409
 ;;^UTILITY(U,$J,358.3,49362,0)
 ;;=A81.01^^187^2447^10
 ;;^UTILITY(U,$J,358.3,49362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49362,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Variant
 ;;^UTILITY(U,$J,358.3,49362,1,4,0)
 ;;=4^A81.01
 ;;^UTILITY(U,$J,358.3,49362,2)
 ;;=^336701
 ;;^UTILITY(U,$J,358.3,49363,0)
 ;;=A81.89^^187^2447^7
 ;;^UTILITY(U,$J,358.3,49363,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49363,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
 ;;^UTILITY(U,$J,358.3,49363,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,49363,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,49364,0)
 ;;=A81.2^^187^2447^27
 ;;^UTILITY(U,$J,358.3,49364,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49364,1,3,0)
 ;;=3^Progressive Multifocal Leukoencephalopathy
 ;;^UTILITY(U,$J,358.3,49364,1,4,0)
 ;;=4^A81.2
 ;;^UTILITY(U,$J,358.3,49364,2)
 ;;=^5000411
 ;;^UTILITY(U,$J,358.3,49365,0)
 ;;=B20.^^187^2447^17
 ;;^UTILITY(U,$J,358.3,49365,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49365,1,3,0)
 ;;=3^HIV Disease w/ Dementia w/ Bhv Dstrb
 ;;^UTILITY(U,$J,358.3,49365,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,49365,2)
 ;;=^5000555^F02.81
 ;;^UTILITY(U,$J,358.3,49366,0)
 ;;=B20.^^187^2447^18
